Scopus
🔓 Açık Erişim YÖKSİS DOI Eşleşti
SJR Q1
SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Journal of Experimental Medicine · Nisan 2021
Özet
Multisystem inflammatory syndrome in children (MIS-C) emerged in April 2020 in communities with high COVID-19 rates. This new condition is heterogenous but resembles Kawasaki disease (KD), a well-known but poorly understood and clinically heterogenous pediatric inflammatory condition for which weak associations have been found with a myriad of viral illnesses. Epidemiological data clearly indicate that SARS-CoV-2 is the trigger for MIS-C, which typically occurs about 1 mo after infection. These findings support the hypothesis of viral triggers for the various forms of classic KD. We further suggest that rare inborn errors of immunity (IEIs) altering the immune response to SARS-CoV-2 may underlie the pathogenesis of MIS-C in some children. The discovery of monogenic IEIs underlying MIS-C would shed light on its pathogenesis, paving the way for a new genetic approach to classic KD, revisited as a heterogeneous collection of IEIs to viruses.
YÖKSİS Kayıtları
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Journal of Experimental Medicine · 2021 SCI-Expanded
Prof. Dr. JALE BENGİ ÇELİK →
SARS-CoV-2\u2013related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Journal of Experimental Medicine · 2021 SCI-Expanded
Prof. Dr. MELİKE EMİROĞLU →
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Journal of Experimental Medicine · 2021 SCI-Expanded
Prof. Dr. JALE BENGİ ÇELİK →
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Journal of Experimental Medicine · 2021 SCI-Expanded
Doç. Dr. GÜLSÜM ALKAN →
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Journal of Experimental Medicine · 2021 SCI-Expanded
Prof. Dr. JALE BENGİ ÇELİK →
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Journal of Experimental Medicine · 2021 SCI-Expanded
Prof. Dr. MELİKE EMİROĞLU →
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Journal of Experimental Medicine · 2021 SCI-Expanded
Doç. Dr. GÜLSÜM ALKAN →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 9 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 9 kaydı bulundu.
SARS-CoV-2\u2013related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
2021 ISSN: 0022-1007 SCI-Expanded Q1
Prof. Dr. MELİKE EMİROĞLU →
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
2021 ISSN: 0022-1007 SCI-Expanded Q1
Doç. Dr. GÜLSÜM ALKAN →
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
2022 ISSN: 0022-1007 SCI-Expanded Q1
Doç. Dr. GÜLSÜM ALKAN →
Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis.
2023 ISSN: 0022-1007 SCI-Expanded Q1
Prof. Dr. MELİKE EMİROĞLU →
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
2021 ISSN: 0022-1007 SCI-Expanded Q1
Prof. Dr. JALE BENGİ ÇELİK →
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
2024 ISSN: 0022-1007 SCI-Expanded Q1
Doç. Dr. GÜLSÜM ALKAN →
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)
2024 ISSN: 0022-1007 SCI-Expanded Q1
Doç. Dr. GÜLSÜM ALKAN →
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)
2024 ISSN: 0022-1007 SCI-Expanded Q1
Prof. Dr. MELİKE EMİROĞLU →
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
2021 ISSN: 0022-1007 SCI-Expanded Q1
Prof. Dr. JALE BENGİ ÇELİK →
Makale Bilgileri
Toplam Atıf
137 atıf
· Scopus
ISSN00221007
Yayın TarihiNisan 2021
Cilt / Sayfa218
Scopus ID2-s2.0-85105542114
Erişim🔓 Açık Erişim
Kurumlar
Ankara City Hospital
Ankara Turkey
Ankara Yildirim Beyazit University
Ankara Turkey
Atatürk Üniversitesi
Erzurum Turkey
Balıkesir Atatürk City Hospital
Balikesir Turkey
BC Children's Hospital Research Institute
Vancouver Canada
Bilkent Üniversitesi
Ankara Turkey
Bursa City Hospital
Bursa Turkey
CEDOC
Lisbon Portugal
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
Madrid Spain
Centro de Regulacion Genomica, Barcelona
Barcelona Spain
Centro Hospitalar Universitário de Santo António
Porto Portugal
Charles University
Prague Czech Republic
Childern's Hospital Zagreb
Zagreb Croatia
CHU de Lyon
Lyon France
CHU Sainte-Justine - Le Centre Hospitalier Universitaire Mère-Enfant
Montreal Canada
Columbia University
New York United States
Complejo Asistencial Universitario de Burgos
Burgos Spain
Departement Microbiologie, Immunologie en Transplantatie
Leuven Belgium
Dr Ali Kemal Belviranli Hospital for Obstetrics and Pediatrics
Konya Turkey
Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital
Ankara Turkey
Fakultní Nemocnice v Motole
Prague Czech Republic
Garvan Institute of Medical Research
Sydney Australia
Hassan II University of Casablanca
Casablanca Morocco
Hôpital Necker Enfants Malades
Paris France
Hospital de Dona Estefânia
Lisbon Portugal
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria Spain
Hospital Duran i Reynals
Barcelona Spain
Hospital Sant Joan de Déu Barcelona
Esplugues de Llobregat Spain
Hospital Universitari Germans Trias i Pujol
Badalona Spain
Hospital Universitario La Paz
Madrid Spain
Hospital Universitario Nuestra Senora de Candelaria
Santa Cruz de Tenerife Spain
Howard Hughes Medical Institute
Chevy Chase United States
Icahn School of Medicine at Mount Sinai
New York United States
Imperial College Faculty of Medicine
London United Kingdom
Imperial College London
London United Kingdom
Inserm
Paris France
Institució Catalana de Recerca i Estudis Avançats
Barcelona Spain
Instituto de Investigación Hospital 12 de Octubre
Madrid Spain
Instituto de Salud Carlos III
Madrid Spain
Instituto Tecnológico y de Energías Renovables, S.A.
Granadilla de Abona Spain
Institut Pasteur, Paris
Paris France
Interdepartmental Group of Immunodeficiencies
Madrid Spain
IRCCS Ospedale Pediatrico Bambino Gesù
Rome Italy
İstanbul Medipol Üniversitesi
Istanbul Turkey
İstanbul Tıp Fakültesi
Istanbul Turkey
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine
Istanbul Turkey
Josip Juraj Strossmayer University of Osijek Faculty of Medicine
Osijek Croatia
Karadeniz Teknik Üniversitesi Tip Fakültesi
Trabzon Turkey
Karolinska Institutet
Stockholm Sweden
King Saud University
Riyadh Saudi Arabia
Konya City Hospital
Konya Turkey
KU Leuven– University Hospital Leuven
Leuven Belgium
Mansoura University Children's Hospital
Mansoura Egypt
Navarra Health Service Hospital
Pamplona Spain
Necmettin Erbakan Üniversitesi
Meram Turkey
Ondokuz Mayis Üniversitesi
Samsun Turkey
Prof. Dr. Cemil Tascioglu City Hospital
Istanbul Turkey
Rockefeller University
New York United States
Selçuk Tip Fakültesi
Konya Turkey
Selçuk Üniversitesi
Selçuklu Turkey
The Children's Hospital of Philadelphia
Philadelphia United States
The University of British Columbia
Vancouver Canada
Universidad de la Laguna
San Cristobal de La Laguna Spain
Universidad Fernando Pessoa Canarias
Santa Maria de Guia de Gran Canaria Spain
Università degli Studi di Roma "Tor Vergata"
Rome Italy
Universitair Ziekenhuis Gent
Ghent Belgium
Universitat Autònoma de Barcelona
Cerdanyola del Valles Spain
Università Vita-Salute San Raffaele
Milan Italy
Université Claude Bernard Lyon 1
Villeurbanne France
Université Paris Cité
Paris France
University of Health Sciences
Istanbul Turkey
University of Pennsylvania Perelman School of Medicine
Philadelphia United States
UNSW Medicine
Kensington Australia
Yale School of Medicine
New Haven United States
Son Atıflar
Angiotensin-Converting Enzyme 1 (ACE1) gene polymorphisms in pediatric patients with COVID-19: impact on disease severity and outcomes
BMC Medical Genomics
· 2026 · DOI
The OAS–RNase L pathway: Insights from experiments of nature
Science Immunology
· 2026 · DOI
Kawasaki disease vs. MIS-C in a child with congenital coronary artery anomaly: a case report
Frontiers in Pediatrics
· 2026 · DOI
Laboratory criteria for neuroimmunoendocrine dysregulation in multisystem inflammatory syndrome associated with SARS-CoV-2 in children
Infektsionnye Bolezni
· 2026 · DOI
Post-pandemic Trends in Giant Coronary Aneurysms in Kawasaki Disease
Pediatric Cardiology
· 2026 · DOI
Cytokine and Whole-Genome Sequence Analysis in Korean Patients With Multisystem Inflammatory Syndrome in Children
Journal of Korean Medical Science
· 2025 · DOI
Type I IFNs Decrease SARS-CoV-2 Replication in Human Cardiomyocytes and Increase Cytokine Production in Macrophages
Journal of Clinical Immunology
· 2025 · DOI
The seven enigmas of SARS-CoV-2: From the past to the future
Journal of Human Immunity
· 2025 · DOI
Unravelling γδ T-cell dysregulation in the gut and its implications for immune-mediated diseases
Dmm Disease Models and Mechanisms
· 2025 · DOI
Identification and clinical validation of immune-related genes as potential diagnostic and therapeutic targets in Kawasaki disease
Aip Advances
· 2025 · DOI
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 137.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Journal of Experimental Medicine
Q1
SJR Skoru5,830
H-Index513
YayıncıRockefeller University Press
ÜlkeUnited States
Immunology (Q1)
Immunology and Allergy (Q1)
Medicine (miscellaneous) (Q1)
Metrikler
137
Atıf